Screening compound: InChI=1S/C12H21N3O5S/c1-18-8-5-11-13-12(20-14-11)9-19-10-3-6-15(7-4-10)21(2,16)17/h10H,3-9H2,1-2H3

Screening compound: InChI=1S/C12H21N3O5S/c1-18-8-5-11-13-12(20-14-11)9-19-10-3-6-15(7-4-10)21(2,16)17/h10H,3-9H2,1-2H3
Screening compound: InChI=1S/C12H21N3O5S/c1-18-8-5-11-13-12(20-14-11)9-19-10-3-6-15(7-4-10)21(2,16)17/h10H,3-9H2,1-2H3 alternative view

Chemical Structure Depiction of ChemDiv screening compound
InChI=1S/C12H21N3O5S/c1-18-8-5-11-13-12(20-14-11)9-19-10-3-6-15(7-4-10)21(2,16)17/h10H,3-9H2,1-2H3

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

S211-1081

Molecular Formula

C12H21N3O5S (C12 H21 N3 O5 S)

Compound Name

1-methanesulfonyl-4-{[3-(2-methoxyethyl)-1,2,4-oxadiazol-5-yl]methoxy}piperidine

IUPAC name

1-methanesulfonyl-4-{[3-(2-methoxyethyl)-124-oxadiazol-5-yl]methoxy}piperidine

SMILES

COCCc1noc(COC(CC2)CCN2S(C)(=O)=O)n1

InChI

InChI=1S/C12H21N3O5S/c1-18-8-5-11-13-12(20-14-11)9-19-10-3-6-15(7-4-10)21(2,16)17/h10H,3-9H2,1-2H3

InChI Key

XJGPADXPUHHZST-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD29031810

InChI=1S/C12H21N3O5S/c1-18-8-5-11-13-12(20-14-11)9-19-10-3-6-15(7-4-10)21(2,16)17/h10H,3-9H2,1-2H3 in Drug Discovery

Included in Screening Libraries

Arginase Targeted Library (2009 compounds)

Bcl2-PPI Inhibitors Library (12246 compounds)

CNS MPO Library (28609 compounds)

Protein-Protein Interaction Library (218420 compounds)

Akt-Targeted Library (14764 compounds)

Beyond the Flatland Library sp3 enriched (92988 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Musculoskeletal
  • Male
  • Cardiovascular
  • Cancer
  • Hemic and lymphatic
  • Nervous system
  • Digestive system
  • Respiratory tract
  • Male
  • Female
  • Hemic and lymphatic
  • Skin
Targets:
  • Others
  • Kinases
Mechanism of action:
  • PPI modulators
  • PPI modulators
Structure:
  • Cyclic compounds

References: we are preparing a list of scientific research reports with InChI=1S/C12H21N3O5S/c1-18-8-5-11-13-12(20-14-11)9-19-10-3-6-15(7-4-10)21(2,16)17/h10H,3-9H2,1-2H3 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound InChI=1S/C12H21N3O5S/c1-18-8-5-11-13-12(20-14-11)9-19-10-3-6-15(7-4-10)21(2,16)17/h10H,3-9H2,1-2H3?
Check Price and Availability of InChI=1S/C12H21N3O5S/c1-18-8-5-11-13-12(20-14-11)9-19-10-3-6-15(7-4-10)21(2,16)17/h10H,3-9H2,1-2H3, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of InChI=1S/C12H21N3O5S/c1-18-8-5-11-13-12(20-14-11)9-19-10-3-6-15(7-4-10)21(2,16)17/h10H,3-9H2,1-2H3 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for InChI=1S/C12H21N3O5S/c1-18-8-5-11-13-12(20-14-11)9-19-10-3-6-15(7-4-10)21(2,16)17/h10H,3-9H2,1-2H3
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for InChI=1S/C12H21N3O5S/c1-18-8-5-11-13-12(20-14-11)9-19-10-3-6-15(7-4-10)21(2,16)17/h10H,3-9H2,1-2H3
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of InChI=1S/C12H21N3O5S/c1-18-8-5-11-13-12(20-14-11)9-19-10-3-6-15(7-4-10)21(2,16)17/h10H,3-9H2,1-2H3 available by request